What efficacy measures are clinically relevant and should be used in Cochrane Reviews of acute migraine trials? A viewpoint

2 Citationer (Scopus)

Abstrakt

BACKGROUND: Cochrane Reviews are methodologically of high quality but the clinical relevance of analysed efficacy measures (EMs) should also be assessed.

METHODS: The clinical relevance of EMs used in one systematic Cochrane review of oral zolmitriptan for migraine headache was evaluated.

RESULTS: The following EMs were used: pain free at two hours (30%), headache relief at two hours (60%), sustained pain free for 24 hours (19%) and sustained headache relief for 24 hours (39%). These EMs were also used in four other Cochrane reviews of acute migraine treatment. Of these EMs sustained headache relief for 24 h is not judged clinically relevant.

CONCLUSION: Pain free and sustained pain free are clinically relevant, but the responses are rather low, demonstrating that there is a need for improvement of acute drug treatment in migraine.

OriginalsprogEngelsk
TidsskriftCephalalgia : an international journal of headache
Vol/bind35
Udgave nummer5
Sider (fra-til)457-459
ISSN0333-1024
DOI
StatusUdgivet - 2015

Fingeraftryk

Dyk ned i forskningsemnerne om 'What efficacy measures are clinically relevant and should be used in Cochrane Reviews of acute migraine trials? A viewpoint'. Sammen danner de et unikt fingeraftryk.

Citationsformater